Alignment Healthcare, Inc. (NASDAQ:ALHC) Insider Sells $231,630.00 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Dawn Christine Maroney sold 23,163 shares of Alignment Healthcare stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $10.00, for a total value of $231,630.00. Following the completion of the sale, the insider now directly owns 1,892,934 shares of the company’s stock, valued at $18,929,340. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Friday, July 19th, Dawn Christine Maroney sold 36,700 shares of Alignment Healthcare stock. The shares were sold at an average price of $10.01, for a total value of $367,367.00.
• On Wednesday, June 12th, Dawn Christine Maroney sold 20,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $8.21, for a total value of $164,200.00.

Alignment Healthcare Stock Up 0.7 %

Shares of NASDAQ ALHC opened at $10.07 on Monday. The company has a market capitalization of $1.93 billion, a price-to-earnings ratio of -11.99 and a beta of 1.43. The company has a debt-to-equity ratio of 1.23, a current ratio of 1.57 and a quick ratio of 1.57. The business has a 50-day moving average of $7.92 and a two-hundred day moving average of $6.68. Alignment Healthcare, Inc. has a 1 year low of $4.46 and a 1 year high of $10.10.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Thursday, May 2nd. The company reported ($0.25) earnings per share for the quarter, missing the consensus estimate of ($0.24) by ($0.01). Alignment Healthcare had a negative net margin of 7.81% and a negative return on equity of 91.06%. The firm had revenue of $628.60 million during the quarter, compared to analysts’ expectations of $599.75 million. During the same period in the previous year, the firm posted ($0.20) earnings per share. The firm’s revenue for the quarter was up 43.1% on a year-over-year basis. On average, analysts forecast that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Baird R W upgraded Alignment Healthcare to a “strong-buy” rating in a report on Thursday, May 30th. Robert W. Baird assumed coverage on Alignment Healthcare in a report on Thursday, May 30th. They issued an “outperform” rating and a $10.00 target price for the company. Bank of America upgraded Alignment Healthcare from a “neutral” rating to a “buy” rating and lifted their target price for the company from $7.75 to $11.00 in a report on Thursday, May 30th. Piper Sandler upgraded Alignment Healthcare from a “neutral” rating to an “overweight” rating and lifted their target price for the company from $6.00 to $8.00 in a report on Wednesday, May 8th. Finally, Stifel Nicolaus decreased their target price on Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating for the company in a report on Tuesday, April 23rd. One research analyst has rated the stock with a sell rating, two have issued a hold rating, six have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $9.11.

Institutional Trading of Alignment Healthcare

Several institutional investors and hedge funds have recently made changes to their positions in ALHC. Hood River Capital Management LLC lifted its holdings in shares of Alignment Healthcare by 49.6% in the 1st quarter. Hood River Capital Management LLC now owns 2,920,836 shares of the company’s stock valued at $14,487,000 after purchasing an additional 968,637 shares during the last quarter. Vanguard Group Inc. increased its position in Alignment Healthcare by 3.7% in the 3rd quarter. Vanguard Group Inc. now owns 9,121,432 shares of the company’s stock valued at $63,303,000 after acquiring an additional 322,661 shares during the period. Assenagon Asset Management S.A. increased its position in Alignment Healthcare by 283.9% in the 1st quarter. Assenagon Asset Management S.A. now owns 315,629 shares of the company’s stock valued at $1,566,000 after acquiring an additional 233,417 shares during the period. Jacobs Levy Equity Management Inc. acquired a new position in Alignment Healthcare in the 1st quarter valued at about $918,000. Finally, Blue Trust Inc. increased its position in Alignment Healthcare by 47.4% in the 1st quarter. Blue Trust Inc. now owns 256,452 shares of the company’s stock valued at $1,272,000 after acquiring an additional 82,476 shares during the period. 86.19% of the stock is owned by hedge funds and other institutional investors.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.